Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GpsB is an essential bacterial protein in Neisseria gonorrhoeae that plays a critical role in coordinating cell division and cell wall synthesis. It acts as a molecular scaffold or interaction hub, facilitating the recruitment and organization of key enzymes, such as penicillin-binding proteins (PBPs), to the site of division (the septum). Recent research has identified GpsB as a novel and promising therapeutic target because its depletion leads to severe defects in cell morphology, including cell enlargement and lysis, effectively halting bacterial proliferation. As N. gonorrhoeae continues to develop resistance to existing antibiotics, targeting GpsB offers a potential pathway for a new class of antimicrobials that disrupt the fundamental machinery of bacterial cytokinesis. Its role is particularly vital in coccoid bacteria, where it helps manage the complex geometry of division in multiple planes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GpsB.